- Home
- PYPD vs NTWK Comparison
PYPD vs NTWK Comparison
Compare PYPD & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- NTWK
- Stock Information
- Founded
- PYPD 2008
- NTWK 1997
- Country
- PYPD Israel
- NTWK United States
- Employees
- PYPD N/A
- NTWK N/A
- Industry
- PYPD Medical/Dental Instruments
- NTWK Computer Software: Prepackaged Software
- Sector
- PYPD Health Care
- NTWK Technology
- Exchange
- PYPD Nasdaq
- NTWK Nasdaq
- Market Cap
- PYPD 36.0M
- NTWK 33.8M
- IPO Year
- PYPD 2020
- NTWK 1998
- Fundamental
- Price
- PYPD $3.50
- NTWK $3.29
- Analyst Decision
- PYPD Strong Buy
- NTWK
- Analyst Count
- PYPD 5
- NTWK 0
- Target Price
- PYPD $11.40
- NTWK N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- NTWK 16.7K
- Earning Date
- PYPD 08-13-2025
- NTWK 05-14-2025
- Dividend Yield
- PYPD N/A
- NTWK N/A
- EPS Growth
- PYPD N/A
- NTWK N/A
- EPS
- PYPD N/A
- NTWK 0.02
- Revenue
- PYPD N/A
- NTWK $64,127,568.00
- Revenue This Year
- PYPD N/A
- NTWK N/A
- Revenue Next Year
- PYPD N/A
- NTWK N/A
- P/E Ratio
- PYPD N/A
- NTWK $162.86
- Revenue Growth
- PYPD N/A
- NTWK 9.18
- 52 Week Low
- PYPD $2.30
- NTWK $2.14
- 52 Week High
- PYPD $4.42
- NTWK $3.38
- Technical
- Relative Strength Index (RSI)
- PYPD 56.01
- NTWK 78.60
- Support Level
- PYPD $3.42
- NTWK $3.10
- Resistance Level
- PYPD $3.62
- NTWK $2.98
- Average True Range (ATR)
- PYPD 0.18
- NTWK 0.11
- MACD
- PYPD -0.03
- NTWK 0.03
- Stochastic Oscillator
- PYPD 60.51
- NTWK 84.08
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.